Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (250)
- Medicine safety (167)
- Prescription medicines (150)
- COVID-19 (144)
- Regulatory compliance (130)
- COVID-19 vaccines (88)
- Legislation (83)
- Therapeutic goods regulation (75)
- Listed medicines (57)
- Non-prescription medicines (53)
- Safety (51)
- Medical devices safety (45)
- Complementary medicines (40)
- Vaping hub (39)
- Manufacturing (36)
- Over the counter (OTC) medicines (33)
- Labelling and packaging (30)
- Assessed listed medicines (26)
- Australian Register of Therapeutic Goods (ARTG) (26)
- Scheduling (national classification system) (24)
- Compliance and enforcement hub (23)
- Alert/Advisory (22)
- Medicinal cannabis hub (21)
- Import and export (19)
- Shortages (13)
- In Vitro Diagnostic medical devices (IVDs) (11)
- Sunscreens (11)
- Weight loss products (11)
- Advisory bodies and committees (5)
- Biological medicines (4)
- Cosmetics (4)
- Registered complementary medicines (4)
- Blood and blood components (3)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Advanced therapies (1)
- Blood safety (1)
- Breast implant hub (1)
- Travelling with health products (1)
Search
1112 result(s) found, displaying 51 to 75
-
Therapeutic Goods (Special Access Scheme - Application and Notification Forms) Approval (No. 2) 2024
NoticesThis instrument is made under the Therapeutic Goods Regulations 1990, the Therapeutic Goods (Medical Devices) Regulations 2002 and the Therapeutic Goods Act 1989. -
Media releasesThe defendant faces a maximum penalty of 12 months’ imprisonment and/or a fine of up to $222,000 for each charge.
-
NewsRecall reforms program update and preview of the PRAC Version 1.0.
-
Safety updatesTCMs sold in Australia are carefully regulated to ensure safety and quality.
-
Media releasesThe TGA and cooperating agencies have seized a large volume of alleged illicit vapes, tobacco and other substances in coordinated operations across Australia.
-
Media releasesWe have issued infringement notices totalling $37,560 for the alleged unlawful possession of a commercial quantity of vaping goods.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
NoticesMRA GMP clearances that are expiring on 31 December 2024 will be automatically extended.
-
NewsFind out about new requirements for labels of injectable electrolyte medicines and updates to guidance for medicine sponsors.
-
BlogIf your business sells or advertises paracetamol, then you need to be aware of the new rules around pack sizes that commence on 1 February 2025.
-
BlogWe know that paracetamol is safe and effective for most people when taken at the recommended dose.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesThis instrument is made under section 39 of the current Poisons Standard.
-
NoticesWe are providing a 12-month period of labelling exemptions for signal words for certain Pharmacy medicine and Pharmacist Only medicine products.
-
NewsWe have introduced new features to improve your experience using Guidance on our website.
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Safety updatesHealth professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age.
-
Media releasesThe TGA has settled judicial review proceedings brought by InstantScripts in respect of infringement notices issued to it by the TGA.
-
Media releasesIn a significant move against the illicit vaping market, the TGA has played a vital role in joint enforcement activity with Victoria Police, resulting in the seizure of 200,000 vapes, worth more than $8 million
-
Safety updatesWe have received Australian reports of Guillain-Barré Syndrome (GBS) following Shingrix vaccination.
-
Media releasesTGA has taken further action to combat the unlawful sale of vapes in Queensland, issuing an infringement notice to a retailer for the unlawful possession of a commercial quantity of vaping goods
-
Safety updatesInformation for health professionals about medicines with safety related updates to their Product Information.
-
Media releasesThe TGA worked alongside Victoria Police officers as part of an ongoing investigation targeting a significant crime syndicate involved in the illicit tobacco market.
-
Media releasesThe 3G network shutdown may impact certain medical devices. Consumers, healthcare providers, manufacturers, and suppliers should take precautions to prevent disruption in essential medical services.
-
Media releasesWe are aware of misinformation that claims the COVID-19 mRNA vaccines are contaminated with excessive levels of DNA. This is not the case.